Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125319571 | 12531957 | 1 | I | 2011 | 20160630 | 20160706 | 20160706 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-43074BP | BOEHRINGER INGELHEIM | 0.00 | M | Y | 0.00000 | 20160706 | MD | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125319571 | 12531957 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 300 MG | 22512 | 150 | MG | CAPSULE | BID | ||||||
| 125319571 | 12531957 | 2 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 0 | 25 | MG | BID | ||||||||
| 125319571 | 12531957 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 10 | MG | BID | ||||||||
| 125319571 | 12531957 | 4 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 125319571 | 12531957 | 5 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | |||||||||
| 125319571 | 12531957 | 6 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125319571 | 12531957 | 7 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0 | .4 | MG | QD | ||||||||
| 125319571 | 12531957 | 8 | C | MILK THISTLE | MILK THISTLE | 1 | Oral | 0 | QD | ||||||||||
| 125319571 | 12531957 | 9 | C | SAW PALMETTO | SAW PALMETTO | 1 | Oral | 0 | QD | ||||||||||
| 125319571 | 12531957 | 10 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 125319571 | 12531957 | 11 | C | POTASSIUM SUPPLEMENT | POTASSIUM | 1 | Oral | 0 | 10 | MEQ | QD | ||||||||
| 125319571 | 12531957 | 12 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125319571 | 12531957 | 1 | Atrial fibrillation |
| 125319571 | 12531957 | 2 | Hypertension |
| 125319571 | 12531957 | 3 | Hypertension |
| 125319571 | 12531957 | 4 | Diuretic therapy |
| 125319571 | 12531957 | 5 | Diuretic therapy |
| 125319571 | 12531957 | 6 | Blood cholesterol increased |
| 125319571 | 12531957 | 7 | Prostatic disorder |
| 125319571 | 12531957 | 8 | Prophylaxis |
| 125319571 | 12531957 | 9 | Prostatic disorder |
| 125319571 | 12531957 | 10 | Product used for unknown indication |
| 125319571 | 12531957 | 11 | Product used for unknown indication |
| 125319571 | 12531957 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125319571 | 12531957 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125319571 | 12531957 | Brain neoplasm | |
| 125319571 | 12531957 | Cardiac failure congestive | |
| 125319571 | 12531957 | Deafness | |
| 125319571 | 12531957 | Fall | |
| 125319571 | 12531957 | Hypoaesthesia | |
| 125319571 | 12531957 | Osteoarthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125319571 | 12531957 | 1 | 2011 | 0 |